Clinical Trial Update: A Study of Intrapleural Administration of Bevacizumab and Camrelizumab for Malignant Pleural Effusion [Phase 1, Phase 2]

View source ↗

Summary

A combined Phase 1/2 clinical trial evaluating intrapleural administration of bevacizumab and camrelizumab for malignant pleural effusion is ongoing with unknow…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Effusion

Drugs mentioned

• Bevacizumab (bevacizumab)
• Camrelizumab (camrelizumab)

Snippet

Sponsor: The First Affiliated Hospital of Zhengzhou University | Conditions: Malignant Pleural Effusion | Phase 1, Phase 2 | Status: UNKNOWN